Developing vaccines to protect against future pandemics
The UCI Vaccines for Pandemic Preparedness Center (VPPC)
This study is working on making quick and safe vaccines to help protect people from new diseases, especially those who are most at risk, while also teaching future scientists how to keep improving vaccine development for better health security.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10863336 on NIH RePORTER |
What this research studies
This research focuses on creating safe and effective vaccines that can be rapidly deployed to protect vulnerable populations from emerging infectious diseases. The approach emphasizes agility in vaccine development, aiming to produce vaccines within 100 days of identifying a new pathogen. The project also includes educational initiatives to train future vaccine scientists, ensuring ongoing advancements in pandemic preparedness. By leveraging lessons learned from past outbreaks, particularly COVID-19, the research aims to enhance global health security.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals in high-risk groups for infectious diseases, such as the elderly, immunocompromised individuals, and frontline healthcare workers.
Not a fit: Patients who are not at risk for infectious diseases or those who do not receive vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the rapid availability of vaccines that protect against future pandemics, potentially saving countless lives.
How similar studies have performed: Previous research has shown success in rapid vaccine development during the COVID-19 pandemic, indicating that this approach has potential for future applications.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Felgner, Philip Louis — University of California-Irvine
- Study coordinator: Felgner, Philip Louis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.